Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 172801, 13 pages
http://dx.doi.org/10.1155/2015/172801
Review Article

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease

1Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora 3086, VIC, Australia
2Department of Rehabilitation, Nutrition and Sport, La Trobe University, Bundoora 3086, VIC, Australia

Received 26 September 2014; Revised 23 February 2015; Accepted 23 February 2015

Academic Editor: Gabriella Calviello

Copyright © 2015 J. Thomas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Daviglus, C. C. Bell, W. Berrettini et al., “National Institutes of Health state-of-the-science conference statement: preventing Alzheimer disease and cognitive decline,” Annals of Internal Medicine, vol. 153, no. 3, pp. 176–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization and Alzheimer's Disease International, Dementia: A Public Health Priority, 2012, http://www.who.int/mental_health/publications/dementia_report_2012/en/.
  3. B. Shatenstein, M. J. Kergoat, and I. Reid, “Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls,” Journal of the American Dietetic Association, vol. 107, no. 12, pp. 2091–2099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Gu, J. W. Nieves, Y. Stern, J. A. Luchsinger, and N. Scarmeas, “Food combination and alzheimer disease risk: a protective diet,” Archives of Neurology, vol. 67, no. 6, pp. 699–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Laitinen, T. Ngandu, S. Rovio et al., “Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study,” Dementia and Geriatric Cognitive Disorders, vol. 22, no. 1, pp. 99–107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. B. Lopez, D. Kritz-Silverstein, and E. Barrett-Connor, “HIgh dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the rancho bernardo study,” Journal of Nutrition, Health and Aging, vol. 15, no. 1, pp. 25–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Luchsinger and R. Mayeux, “Dietary factors and Alzheimer's disease,” The Lancet Neurology, vol. 3, no. 10, pp. 579–587, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Scarmeas, Y. Stern, M.-X. Tang, R. Mayeux, and J. A. Luchsinger, “Mediterranean diet and risk for Alzheimer's disease,” Annals of Neurology, vol. 59, no. 6, pp. 912–921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Opie, R. A. Ralston, and K. Z. Walker, “Adherence to a mediterranean-style diet can slow the rate of cognitive decline and decrease the risk of dementia: a systematic review,” Nutrition and Dietetics, vol. 70, no. 3, pp. 206–217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Sofi, F. Cesari, R. Abbate, G. F. Gensini, and A. Casini, “Adherence to mediterranean diet and health status: meta-analysis,” British Medical Journal, vol. 337, p. a1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. Bayer-Carter, P. S. Green, T. J. Montine et al., “Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment,” Archives of Neurology, vol. 68, no. 6, pp. 743–752, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Karczewska-Kupczewska, I. Kowalska, A. Nikołajuk et al., “Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fatmeal in young healthymale subjects,” Diabetes Care, vol. 35, no. 2, pp. 358–362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. E. Ramsden, A. Ringel, A. E. Feldstein et al., “Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 87, no. 4-5, pp. 135–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. E. Ramsden, K. R. Faurot, D. Zamora et al., “Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial,” Pain, vol. 154, no. 11, pp. 2441–2451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-C. Chiu, K.-P. Su, T.-C. Cheng et al., “The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 6, pp. 1538–1544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kotani, E. Sakaguchi, S. Warashina et al., “Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction,” Neuroscience Research, vol. 56, no. 2, pp. 159–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L. K. Lee, S. Shahar, A.-V. Chin, and N. A. M. Yusoff, “Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial,” Psychopharmacology, vol. 225, no. 3, pp. 605–612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Cazzola, M. Rondanelli, M. Faliva, and B. Cestaro, “Effects of DHA-phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment,” Experimental Gerontology, vol. 47, no. 12, pp. 974–978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Mahmoudi, M. Hedayat, F. Sharifi et al., “Effect of low dose ω-3 poly unsaturated fatty acids on cognitive status among older people: a double-blind randomized placebo-controlled study,” Journal of Diabetes & Metabolic Disorders, vol. 13, no. 1, article 34, 2014. View at Publisher · View at Google Scholar
  20. P. F. Boston, A. Bennett, D. F. Horrobin, and C. N. Bennett, “Ethyl-EPA in Alzheimer's disease—a pilot study,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 71, no. 5, pp. 341–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Freund-Levi, M. Eriksdotter-Jönhagen, T. Cederholm et al., “Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study - A randomized double-blind trial,” Archives of Neurology, vol. 63, no. 10, pp. 1402–1408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Freund-Levi, H. Basun, T. Cederholm et al., “Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms,” International Journal of Geriatric Psychiatry, vol. 23, no. 2, pp. 161–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Quinn, R. Raman, R. G. Thomas et al., “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial,” Journal of the American Medical Association, vol. 304, no. 17, pp. 1903–1911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. D. Barnard, A. I. Bush,, A. Ceccarelli et al., “Dietary and lifestyle guidelines for the prevention of Alzheimer's disease,” Neurobiology of Aging, vol. 35, supplement 2, pp. S74–S78, 2014. View at Publisher · View at Google Scholar
  25. J.-Y. Han and S.-H. Han, “Primary prevention of Alzheimer's disease: is it an attainable goal?” Journal of Korean Medical Science, vol. 29, no. 7, pp. 886–892, 2014. View at Publisher · View at Google Scholar
  26. P. M. Kris-Etherton, J. A. Grieger, and T. D. Etherton, “Dietary reference intakes for DHA and EPA,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 81, no. 2-3, pp. 99–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. B. C. Davis and P. M. Kris-Etherton, “Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications,” The American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 640S–646S, 2003. View at Google Scholar · View at Scopus
  28. J. T. Brenna, N. Salem Jr., A. J. Sinclair, and S. C. Cunnane, “α-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 80, no. 2-3, pp. 85–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. P. DeFilippis and L. S. Sperling, “Understanding omega-3's,” American Heart Journal, vol. 151, no. 3, pp. 564–570, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. M. Williams and G. Burdge, “Long-chain n-3 PUFA: plant v. marine sources,” Proceedings of the Nutrition Society, vol. 65, no. 1, pp. 42–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Hetz and B. Mollereau, “Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases,” Nature Reviews Neuroscience, vol. 15, no. 4, pp. 233–249, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. G. C. Brown and J. J. Neher, “Inflammatory neurodegeneration and mechanisms of microglial killing of neurons,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 242–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. T. Heneka, J. J. Rodríguez, and A. Verkhratsky, “Neuroglia in neurodegeneration,” Brain Research Reviews, vol. 63, no. 1-2, pp. 189–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Blennow, M. J. de Leon, and H. Zetterberg, “Alzheimer's disease,” The Lancet, vol. 368, no. 9533, pp. 387–403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. H. Kim, S. H. Yeo, J.-M. Park et al., “Genetic markers for diagnosis and pathogenesis of Alzheimer's disease,” Gene, vol. 545, no. 2, pp. 185–193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Lynch and K. H. G. Mills, “Immunology meets neuroscience—opportunities for immune intervention in neurodegenerative diseases,” Brain, Behavior, and Immunity, vol. 26, no. 1, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. T. Heneka, M. P. Kummer, and E. Latz, “Innate immune activation in neurodegenerative disease,” Nature Reviews Immunology, vol. 14, no. 7, pp. 463–477, 2014. View at Publisher · View at Google Scholar
  38. F. Zipp and O. Aktas, “The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases,” Trends in Neurosciences, vol. 29, no. 9, pp. 518–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. P. J. Khandelwal, A. M. Herman, and C. E.-H. Moussa, “Inflammation in the early stages of neurodegenerative pathology,” Journal of Neuroimmunology, vol. 238, no. 1-2, pp. 1–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Badoer, “Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction,” The International Journal of Biochemistry & Cell Biology, vol. 42, no. 10, pp. 1580–1585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, “Mechanisms underlying inflammation in neurodegeneration,” Cell, vol. 140, no. 6, pp. 918–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. M. Esiri, “The interplay between inflammation and neurodegeneration in CNS disease,” Journal of Neuroimmunology, vol. 184, no. 1-2, pp. 4–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Lehrer and P. H. Rheinstein, “Is Alzheimer's disease autoimmune inflammation of the brain that can be treated with nasal nonsteroidal anti-inflammatory drugs?” The American Journal of Alzheimer's Disease and Other Dementias, 2014. View at Publisher · View at Google Scholar
  44. J. Thomas, M. L. Garg, and D. W. Smith, “Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice,” The Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1735–1740, 2013. View at Publisher · View at Google Scholar
  45. S. M. de la Monte, “Type 3 diabetes is sporadic Alzheimer's disease: mini-review,” European Neuropsychopharmacology, vol. 24, no. 12, pp. 1954–1960, 2014. View at Publisher · View at Google Scholar
  46. L. D. Baker, D. J. Cross, S. Minoshima, D. Belongia, G. Stennis Watson, and S. Craft, “Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes,” Archives of Neurology, vol. 68, no. 1, pp. 51–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. M. de la Monte, L. Longato, M. Tong, and J. R. Wands, “Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis,” Current Opinion in Investigational Drugs, vol. 10, no. 10, pp. 1049–1060, 2009. View at Google Scholar · View at Scopus
  48. A. Ott, R. P. Stolk, F. van Harskamp, H. A. P. Pols, A. Hofman, and M. M. B. Breteler, “Diabetes mellitus and the risk of dementia: the Rotterdam Study,” Neurology, vol. 53, no. 9, pp. 1937–1942, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Matsuzaki, K. Sasaki, Y. Tanizaki et al., “Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study,” Neurology, vol. 75, no. 9, pp. 764–770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Velayudhan, M. Poppe, N. Archer, P. Proitsi, R. G. Brown, and S. Lovestone, “Risk of developing dementia in people with diabetes and mild cognitive impairment,” British Journal of Psychiatry, vol. 196, no. 1, pp. 36–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Gauthier, B. Reisberg, M. Zaudig et al., “Mild cognitive impairment,” The Lancet, vol. 367, no. 9518, pp. 1262–1270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. ClinicalTrials.gov, Clinical Trials for Alzheimers Disease, http://www.clinicaltrials.gov/ct2/results?term=alzheimer.
  53. J. R. Hecker and C. A. Snellgrove, “Pharmacological management of Alzheimer's disease,” Journal of Pharmacy Practice and Research, vol. 33, no. 1, pp. 24–29, 2003. View at Google Scholar · View at Scopus
  54. V. Kotsirilos, L. Vitetta, and A. Sali, A Guide to Evidence-Based Integrative and Complementary Medicine, Elsevier, Chatswood, Australia, 2011.
  55. D. W. Luchtman and C. Song, “Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies,” Neuropharmacology, vol. 64, pp. 550–565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. N. G. Bazan and B. L. Scott, “Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses,” Upsala Journal of Medical Sciences, Supplement, no. 48, pp. 97–107, 1990. View at Google Scholar · View at Scopus
  57. J. A. Luchsinger, J. M. Noble, and N. Scarmeas, “Diet and Alzheimer's disease,” Current Neurology and Neuroscience Reports, vol. 7, no. 5, pp. 366–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Itsiopoulos, L. Brazionis, M. Kaimakamis et al., “Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 9, pp. 740–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Yoshida, A. Yoshikawa, T. Kinumi et al., “Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers,” Neurobiology of Aging, vol. 30, no. 2, pp. 174–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. J. D. Moreira, L. Knorr, M. Ganzella et al., “Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations,” Neurochemistry International, vol. 56, no. 6-7, pp. 753–759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Koletzko, E. Larqué, and H. Demmelmair, “Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA),” Journal of Perinatal Medicine, vol. 35, supplement 1, pp. S5–S11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. N. G. Bazan, W. C. Gordon, and E. B. Rodriguez de Turco, “Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process,” Advances in Experimental Medicine and Biology, vol. 318, pp. 295–306, 1992. View at Publisher · View at Google Scholar · View at Scopus
  63. R. E. Martin and N. G. Bazan, “Changing fatty acid content of growth cone lipids prior to synaptogenesis,” Journal of Neurochemistry, vol. 59, no. 1, pp. 318–325, 1992. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Larqué, S. Krauss-Etschmann, C. Campoy et al., “Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins,” The American Journal of Clinical Nutrition, vol. 84, no. 4, pp. 853–861, 2006. View at Google Scholar · View at Scopus
  65. S. R. de Vriese, C. Matthys, S. de Henauw, G. de Backer, M. Dhont, and A. B. Christophe, “Maternal and umbilical fatty acid status in relation to maternal diet,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 6, pp. 389–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. Dunstan, T. A. Mori, A. Barden et al., “Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty composition,” European Journal of Clinical Nutrition, vol. 58, no. 3, pp. 429–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. W. J. Lukiw and N. G. Bazan, “Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease: a review on the bioactivity of neuroprotectin D1 and apoptosis,” Molecular Neurobiology, vol. 42, no. 1, pp. 10–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. J. M. Bourre, “Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2. Macronutrients,” Journal of Nutrition, Health and Aging, vol. 10, no. 5, pp. 386–399, 2006. View at Google Scholar · View at Scopus
  69. H.-M. Su, “Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance,” Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 364–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Akbar, F. Calderon, Z. Wen, and H.-Y. Kim, “Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 10858–10863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. M. A. Crawford, I. Golfetto, K. Ghebremeskel et al., “The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants,” Lipids, vol. 38, no. 4, pp. 303–315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. S. C. Dyall, G. J. Michael, and A. T. Michael-Titus, “Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats,” Journal of Neuroscience Research, vol. 88, no. 10, pp. 2091–2102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Plourde, M. Fortier, M. Vandal et al., “Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 5-6, pp. 301–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. J. A. Conquer, M. C. Tierney, J. Zecevic, W. J. Bettger, and R. H. Fisher, “Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment,” Lipids, vol. 35, no. 12, pp. 1305–1312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. R. S. Greiner, T. Moriguchi, A. Hutton, B. M. Slotnick, and N. Salem Jr., “Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks,” Lipids, vol. 34, no. 1, supplement, pp. S239–S243, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. N. G. Bazan, “Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease,” Journal of Lipid Research, vol. 50, supplement, pp. S400–S405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. G. M. Cole and S. A. Frautschy, “DHA may prevent age-related dementia,” Journal of Nutrition, vol. 140, no. 4, pp. 869–874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Hashimoto, Y. Tanabe, Y. Fujii, R. Hagiwara, H. Yamasaki, and O. Shido, “Mechanism of improvement of spatial cognition with dietary docosahexaenoic acid,” Nihon Yakurigaku Zasshi, vol. 120, no. 1, pp. 54P–56P, 2002. View at Google Scholar
  79. A. Wu, Z. Ying, and F. Gomez-Pinilla, “Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition,” Neuroscience, vol. 155, no. 3, pp. 751–759, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Calon, G. P. Lim, T. Morihara et al., “Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease,” European Journal of Neuroscience, vol. 22, no. 3, pp. 617–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Elgersma, J. D. Sweatt, and K. P. Giese, “Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition,” Journal of Neuroscience, vol. 24, no. 39, pp. 8410–8415, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. M. O. W. Grimm, J. Kuchenbecker, S. Grosgen et al., “Docosahexaenoic acid reduces amyloid β production via multiple pleiotropic mechanisms,” The Journal of Biological Chemistry, vol. 286, no. 16, pp. 14028–14039, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Nishikawa, S. Kimura, and N. Akaike, “Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex,” The Journal of Physiology, vol. 475, no. 1, pp. 83–93, 1994. View at Publisher · View at Google Scholar · View at Scopus
  84. J. S. Poling, J. W. Karanian, N. Salem Jr., and S. Vicini, “Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid,” Molecular Pharmacology, vol. 47, no. 2, pp. 381–390, 1995. View at Google Scholar · View at Scopus
  85. L. A. Horrocks and A. A. Farooqui, “Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 70, no. 4, pp. 361–372, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. D. B. Jump, “Dietary polyunsaturated fatty acids and regulation of gene transcription,” Current Opinion in Lipidology, vol. 13, no. 2, pp. 155–164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Farkas, K. Kitajka, E. Fodor et al., “Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6362–6366, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Kitajka, L. G. Puskás, Á. Zvara et al., “The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2619–2624, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Barceló-Coblijn, K. Kitajka, L. G. Puskás et al., “Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1632, no. 1–3, pp. 72–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. G. P. Lim, F. Calon, T. Morihara et al., “A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model,” Journal of Neuroscience, vol. 25, no. 12, pp. 3032–3040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. J. S. Fernandes, M. A. Mori, R. Ekuni, R. M. W. Oliveira, and H. Milani, “Long-term treatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia,” Nutrition Research, vol. 28, no. 11, pp. 798–808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Pomponi and M. Pomponi, “DHA deficiency and Alzheimer's disease,” Clinical Nutrition, vol. 27, no. 1, p. 170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Delion, S. Chalon, D. Guilloteau, B. Lejeune, J.-C. Besnard, and G. Durand, “Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet,” Journal of Lipid Research, vol. 38, no. 4, pp. 680–689, 1997. View at Google Scholar · View at Scopus
  94. D. Swanson, R. Block, and S. A. Mousa, “Omega-3 fatty acids EPA and DHA: health benefits throughout life,” Advances in Nutrition, vol. 3, no. 1, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Cherubini, C. Andres-Lacueva, A. Martin et al., “Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study,” Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 62, no. 10, pp. 1120–1126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. C.-C. Chiu, S. Frangou, C.-J. Chang et al., “Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression,” American Journal of Clinical Nutrition, vol. 95, no. 2, pp. 420–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. B. Heude, P. Ducimetière, and C. Berr, “Cognitive decline and fatty acid composition of erythrocyte membranes—the EVA Study,” The American Journal of Clinical Nutrition, vol. 77, no. 4, pp. 803–808, 2003. View at Google Scholar · View at Scopus
  98. A. M. Tully, H. M. Roche, R. Doyle et al., “Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study,” British Journal of Nutrition, vol. 89, no. 4, pp. 483–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Sofi, R. Abbate, G. F. Gensini, and A. Casini, “Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis,” The American Journal of Clinical Nutrition, vol. 92, no. 5, pp. 1189–1196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. E. H. Martínez-Lapiscina, P. Clavero, E. Toledo et al., “Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 12, pp. 1318–1325, 2013. View at Publisher · View at Google Scholar · View at Scopus